Bill Title: Prohibits a manufacturer or wholesale distributor from engaging in unrestrained price increases in the sale of an essential off-patent or generic drug

Sponsorship: Partisan Bill (Republican 1)

Status: (Introduced - Dead) 2018-03-21 - Read by title, under the rules, referred to the Committee on Health and Welfare. [HB710 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	Not Avail	PDF	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
House Committee Amendment #2084 H&W Draft	Not Avail	Proposed	PDF	Link	View

Supplemental Documents

Title	Description	Date	Format	Source	View
Analysis	Digest of HB710 Original	Not Avail	PDF	Link	View